Please assess the completion status of the following clinical trial:

Trial Title: Study to Investigate the Safety and Efficacy of K-321 in Patients With Fuchs Endothelial Corneal Dystrophy (FECD) Following Descemetorhexis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Is at least 18 years old at the screening visit (Visit 1).~* Has a diagnosis of FECD at Visit 1.~* Meet all other inclusion criteria outlined in clinical study protocol.~Exclusion Criteria:~* Has a study eye with a history of cataract surgery within 90 days of Visit 1.~* Has a study eye with a history of any previous ocular surgery other than for cataract.~* Meet any other exclusion criteria outlined in clinical study protocol.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- K-321 QID (Type: EXPERIMENTAL): K-321 Ophthalmic Solution Dose A
- K-321 BID (Type: EXPERIMENTAL): K-321 Ophthalmic Solution Dose B
- Placebo (Type: PLACEBO_COMPARATOR): Vehicle Solution Dose

Based on this trial design, predict the completion outcome and termination type (if applicable).